DENTSPLY SIRONA Q1 EPS Estimate Decreased by Zacks Research

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Stock analysts at Zacks Research reduced their Q1 2025 earnings estimates for shares of DENTSPLY SIRONA in a research note issued on Thursday, March 20th. Zacks Research analyst I. Bandyopadhyay now expects that the medical instruments supplier will earn $0.31 per share for the quarter, down from their prior estimate of $0.42. The consensus estimate for DENTSPLY SIRONA’s current full-year earnings is $1.84 per share. Zacks Research also issued estimates for DENTSPLY SIRONA’s Q2 2025 earnings at $0.45 EPS, Q3 2025 earnings at $0.49 EPS, Q4 2025 earnings at $0.56 EPS, FY2025 earnings at $1.81 EPS, Q1 2026 earnings at $0.34 EPS, Q2 2026 earnings at $0.48 EPS, Q3 2026 earnings at $0.49 EPS, Q4 2026 earnings at $0.58 EPS, FY2026 earnings at $1.89 EPS and FY2027 earnings at $2.19 EPS.

Other analysts have also issued reports about the company. Evercore ISI reissued an “in-line” rating and issued a $20.00 price target on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. UBS Group dropped their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research report on Tuesday, December 3rd. Barrington Research decreased their price target on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an “outperform” rating on the stock in a report on Friday, February 28th. Finally, Mizuho dropped their price objective on DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a report on Thursday, March 13th. Twelve research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, DENTSPLY SIRONA has an average rating of “Hold” and a consensus target price of $23.33.

DENTSPLY SIRONA Trading Down 1.5 %

Shares of XRAY opened at $15.57 on Monday. DENTSPLY SIRONA has a fifty-two week low of $14.78 and a fifty-two week high of $33.42. The company has a market capitalization of $3.10 billion, a PE ratio of -7.52, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The stock has a fifty day moving average of $17.86 and a two-hundred day moving average of $20.40. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

Institutional Investors Weigh In On DENTSPLY SIRONA

A number of hedge funds have recently bought and sold shares of XRAY. Riverview Trust Co purchased a new position in shares of DENTSPLY SIRONA during the 4th quarter valued at approximately $26,000. Colonial Trust Co SC acquired a new stake in DENTSPLY SIRONA in the fourth quarter valued at $26,000. MassMutual Private Wealth & Trust FSB boosted its stake in DENTSPLY SIRONA by 648.4% during the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock valued at $27,000 after acquiring an additional 1,232 shares during the last quarter. UMB Bank n.a. grew its holdings in DENTSPLY SIRONA by 60.8% during the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares in the last quarter. Finally, Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in DENTSPLY SIRONA by 700.0% during the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier’s stock worth $33,000 after acquiring an additional 1,568 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

Insider Activity

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the company’s stock in a transaction dated Monday, March 3rd. The shares were acquired at an average cost of $16.51 per share, with a total value of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66 % increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Insiders own 0.52% of the company’s stock.

DENTSPLY SIRONA Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, March 28th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.11%. DENTSPLY SIRONA’s payout ratio is currently -14.07%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.